Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA008045-07
Application #
6287647
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Czechowicz, Dorynne D
Project Start
1993-12-15
Project End
2006-02-28
Budget Start
2001-05-01
Budget End
2002-02-28
Support Year
7
Fiscal Year
2001
Total Cost
$363,678
Indirect Cost
Name
Johns Hopkins University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Tompkins, D Andrew; Smith, Michael T; Mintzer, Miriam Z et al. (2014) A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine. J Pharmacol Exp Ther 348:217-26
Strain, E C; Harrison, J A; Bigelow, G E (2011) Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films. Clin Pharmacol Ther 89:443-9
Duke, Angela N; Correia, Christopher J; Walsh, Sharon L et al. (2010) Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers. Psychopharmacology (Berl) 211:303-12
Tompkins, D Andrew; Bigelow, George E; Harrison, Joseph A et al. (2009) Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug Alcohol Depend 105:154-9
Lanier, Ryan K; Umbricht, Annie; Harrison, Joseph A et al. (2008) Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation. Psychopharmacology (Berl) 198:149-58
Wedam, Erich F; Bigelow, George E; Johnson, Rolley E et al. (2007) QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med 167:2469-75
Rodriguez-Rosas, Maria Esther; Lofwall, Michelle R; Strain, Eric C et al. (2007) Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 850:538-43
Rosado, James; Walsh, Sharon L; Bigelow, George E et al. (2007) Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone. Drug Alcohol Depend 90:261-9
Correia, Christopher J; Walsh, Sharon L; Bigelow, George E et al. (2006) Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period. Psychopharmacology (Berl) 189:297-306
Carroll, C Patrick; Walsh, Sharon L; Bigelow, George E et al. (2006) Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans. Exp Clin Psychopharmacol 14:109-20

Showing the most recent 10 out of 19 publications